Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07042633

Mechanism of Gamma Oscillation Synchronization in the Prefrontal-hippocampal Circuit for Memory Dysfunction in Patients With White Matter Lesions of Cerebral Small Vessel Disease

The mechanism underlying memory impairment caused by white matter lesions of cerebral small vessel disease is still unclear. The disrupted synchronization of gamma oscillations in the prefrontal-hippocampal circuit is a potential key mechanism. Our study has demonstrated that white matter lesions lead to demyelination of the connection tracts between the prefrontal lobe and hippocampus, which is closely related to memory dysfunction. However, further studies are required to explore if these microstructural changes in white matter tracts influence memory function by affecting gamma oscillations. Thus, this project will use the previously established episodic memory task and event-related potential to determine the changes in gamma oscillations in the prefrontal-hippocampal circuit and the effects on memory encoding and retrieval. Combining multimodal imaging, we will explore the mediating role of white matter microstructure damage, and establish a machine learning prediction model for memory impairment. In addition, transcranial alternation current stimulation (tACS) will be used to investigate the mechanisms of memory improvement by regulating the prefrontal-hippocampal gamma oscillations. This project will clarify the neural oscillation mechanism underlying memory impairment caused by white matter lesions of cerebral small vessel disease, with the expectation of providing new predictive indicators and interventions.

Recruiting

Interested in participating?

Request Info

Key information

Age range

55 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Xuanwu Hospital Capital Medical University

Beijing, Beijing Municipality, 100053, China

Location status: Recruiting

Location contact

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • - Individuals with cerebral small vessel disease, normal cognition or mild cognitive impairment subjects;
  • Participants with complete demographic data, neuropsychiatric scale assessments, imaging data, and EEG data.

Exclusion criteria

  • Severe aphasia, physical disability, or other conditions preventing completion of neuropsychological assessments;
  • History of cerebrovascular stroke with documented neurological deficits during onset and corresponding lesions on neuroimaging;
  • Neurological disorders that may cause cognitive impairment, including alcohol abuse, drug addiction, traumatic brain injury, epilepsy, encephalitis, or normal-pressure hydrocephalus;
  • Systemic diseases potentially contributing to mild cognitive impairment (e.g., hepatic/renal insufficiency, endocrine disorders, vitamin deficiencies);
  • Current diagnosis of major depressive disorder or psychiatric disorders.

Treatment and study plan

Primary outcomes

  1. Overall cognitive function

    Time frame: baseline and one-year follow-up

    Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MOCA) scale scores.

Secondary outcomes

  1. Attention and executive functions

    Time frame: Baseline and follow up

    the scores are evaluated using the Clock Drawing Test (CDT), the Digit Span Test (DST), and the Trail Making Test (TMT).

  2. Language function

    Time frame: Baseline and one-year follow up

    Boston Naming Test (BNT)

  3. Memory function

    Time frame: Baseline and one-year follow up

    Digit Span Test (DST) and the WHO-UCLA Auditory Verbal Learning Test (AVLT).

  4. Brain imaging data

    Time frame: baseline and one-year follow-up

    Based on DTI data, the following metrics can be extracted:

    Fractional Anisotropy (FA) Mean Diffusivity (MD) Axial Diffusivity (AD) Radial Diffusivity (RD)

  5. Electroencephalogram (EEG) data.

    Time frame: baseline and one-year follow-up

    Based on EEG data, time-frequency analysis and cross-frequency coupling analysis can be performed to extract the following metrics:

    Theta Band Neural Oscillation Energy Theta-Gamma Coupling Strength

Sponsors and collaborators

Lead sponsor

Xuanwu Hospital, Beijing

Other

Registry information

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Jun 29, 2025
Registry last updated
Jun 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.